SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-029141
Filing Date
2023-06-09
Accepted
2023-06-09 16:30:46
Documents
2
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 9918
2 EXHIBIT 24 brhc20054257_ex24.htm EX-24 5400
  Complete submission text file 0001140361-23-029141.txt   16705
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address
Nguyen AnhCo (Reporting) CIK: 0001977970 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 231005789